Exploring the molecular structural requirements of Withania somnifera (Ashwagandha) as human acetylcholinesterase inhibitors using molecular modelling studies Online publication date: Thu, 12-Jan-2023
by Uttam A. More; Shruti Damania; Parth Desai; Vishalsinh Chauhan; Drashti Dhaduk; Kashish Desai; Malleshappa N. Noolvi
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 15, No. 3, 2022
Abstract: The naturally obtained Withania somnifera (Ashwagandha) also known as Indian Ginseng have gained a lot of interest as potential Alzheimer's therapy candidates because of their neuroprotection, anti-oxidant, immune boosting, memory power enhancing ability, anti-inflammatory and anti-stress properties. However, more research is required to learn more about the specific mechanisms by which phyto-compounds from Withania somnifera may have neuroprotective effects in Alzheimer's disease. According to our research, these phyto-compounds of Withania somnifera like Pubesenolide, Acetyl Withaferin A and Withanolide L is showing medium blood brain barrier level. The molecular docking study revealed that phyto-compounds ofWithania somnifera are binding with AChE CAS site amino acids Gln71, Trp86, Asn87, Tyr124, His447, PAS site amino acid Tyr72, Tyr341, Trp286, and mid gorge amino acid Arg296, Phe297, Phe338. The findings support the use of phytocompounds of Withania somnifera as a small ligand molecule in the treatment and prevention of Alzheimer's disease pathologies.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com